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Letter to Editor
Repeated use of medications for ovulation
induction after unsuccessful treatment:
A cause of concern for infertile couples
Dear Editor,
The field of assisted reproductive technologies (ARTs) is rapidly progressing with
many new advances to help infertile or sub-fertile couples to conceive and finally give
birth (1, 2). The application of ARTs has solved the problems associated with infertility
in many couples and has improved the results of infertility treatment. More than 5
million children have been born through these technologies and about 40 million
couples have benefited after ARTsworldwide (3). However, ARTsmay be associatedwith
complications in women and fetuses after taking prescribed drugs (4). The side effects
of different medications cause concern in couples who try several times to conceive with
ARTs.
In a qualitative study, which was conducted on the experiences of 29 infertile
couples with unsuccessful treatment using face-to-face in-depth interviews, many
participants expressed their experiences of the immediate and long-term complications
of medications used for ovulation induction. The immediate complications included
hyper stimulation, frequent and painful injections, and the local complications of
progesterone injections, which is discussed in more detail:
(1) Some participants experienced ovarian hyperstimulation after taking prescribed
drugs. The ARTs may be associated with severe ovarian hyperstimulation syndrome
(OHSS) (5). OHSS is a rare and potentially life-threatening problem that occurs in the
process of infertility treatment (6).
(2) The majority of participants in the study suffered from frequent and painful
injections. Infertility treatment is hard and frustrating, but infertile women tolerate it
because of the value of its outcome (7). Our study showed that some infertile women
were upset to restart painful procedures after unsuccessful treatment.
(3) Many participants complained of the local complications of progesterone injections
that cause a stiff and painful injection site. One of the participants said that she
had hives after the injection of drugs and needed to use corticosteroids and so was
hospitalized.
The long-term effects of taking medications in our study included
thromboembolic events, weight gain, and birth defects, which has been ellaborated
below:
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(1) Thromboembolic events may be among the long-term effects of taking medications. It is very
important to identify the risk factors for thromboembolic events in OHSS patients. Changes in the
hemostatic system increase the high concentration in women with severe OHSS (6).
(2) Weight gain caused by drug usage was another long-term effect of using ARTs, which was elaborated
by some participants.
(3) Another long-term effect of ARTs emphasized by some participants was birth defects. One of
the participants after two failures of the in-vitro fertilization (IVF) attempt, as well as because of
observing the side effects of drugs on the fetus of one of their counterparts, gave up the treatment
due to the fear of these side effects on her own fetus. Some infertile couples may be afraid of
birth defects, as some studies suggest that birth defects in ARTs-babies are greater than those
born with normal pregnancy (3, 8, 9). They were concerned about the lack of formation of cochlear
in IVF-born babies. In a study, it was shown that ARTs can lead to hearing impairment and ear
disorders, such as cases of bilateral lumbar puncture in the ear, one-sided lumbar puncture from the
tympanum, and inflammation of the unilateral and bilateral tympanic membrane (10). ARTs increase
the risk of Beckwith-Wiedemam syndrome by 10% and can also be involved in the pathogenesis
of genomic diseases in addition to methylation abnormalities (11). Factors such as the lack of
choice of natural mechanisms in ARTs-induced pregnancies, hormonal changes in the laboratory
as the cause of aneuploidy chromosomes, and spot mutations due to exposure to chemicals in
the laboratory may increase congenital abnormalities in ARTs-babies (9). Also, in these methods,
many drugs which are prescribed for ovulation induction, egg retrieval and embryo culture, freezing
and melting embryo under laboratory conditions, and using high doses of progesterone to support
luteal phases, all may cause damages to gametes or embryos (3). Therefore, it seems that the
infertile couples’ fear of the possibility of developing defects in embryos caused by ARTs is a
logical challenge for those who undergo multiple treatments using ARTs. A meta-analysis also
showed that ART methods are introduced as a risk factor for placenta previa (12) and preeclampsia
(13).
We argue that these findings have presented the experiences of Iranian mothers in the context of
Iranian infertility clinics, however, it seems that the experiences of our infertile couples could be similar
to others across the world, regarding their experiences with medications in IVF process. To sum up,
although the studies have shown the maternal and fetal complications with IVF (3, 12), no attention
is drawn to infertile women’s concern on this topic. It seems that it will be useful to develop clinical
practice protocols and guidelines to improve OHSS, reduce multiple pregnancies, and increase live
birth rates (1). Counseling and supportive interventions such as collaborative infertility counselling model,
cognitive-behavioral intervention, and psychosocial interventions may decrease the mentioned concerns
and stress in ARTs (14, 15) and as a consequence could help infertile women to cope better with the
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